Pharmacologic neuroprotection with an inhibitor of nitric oxide synthase for the treatment of glaucoma.
about
Current perspective of neuroprotection and glaucomaMagnetic resonance in studies of glaucomaNeuroprotective effects of bis(7)-tacrine against glutamate-induced retinal ganglion cells damage.Inducible nitric oxide synthase, Nos2, does not mediate optic neuropathy and retinopathy in the DBA/2J glaucoma model.Current concepts in the pathophysiology of glaucomaInducible nitric oxide synthase-mediated alteration of mitochondrial OPA1 expression in ocular hypertensive ratsGlaucoma 2.0: neuroprotection, neuroregeneration, neuroenhancementNeuroprotective and neurite outgrowth effects of maltol on retinal ganglion cells under oxidative stress.Characterization of retinal damage in the episcleral vein cauterization rat glaucoma model.Molecular clustering identifies complement and endothelin induction as early events in a mouse model of glaucomaChemokine-mediated inflammation in the degenerating retina is coordinated by Müller cells, activated microglia, and retinal pigment epitheliumT-helper1/T-helper2 cytokine imbalance in the iris of patients with glaucomaSpatiotemporal Cadence of Macrophage Polarisation in a Model of Light-Induced Retinal DegenerationProtective effects of melatonin in experimental free radical-related ocular diseases.Small interfering RNA-mediated suppression of Ccl2 in Müller cells attenuates microglial recruitment and photoreceptor death following retinal degeneration.The broad-spectrum chemokine inhibitor NR58-3.14.3 modulates macrophage-mediated inflammation in the diseased retina.The role of nitric oxide in osteoarthritis.Safety of intravitreally administered recombinant erythropoietin (an AOS thesis)Ocular disorders and the utility of animal models in the discovery of melatoninergic drugs with therapeutic potential.Therapeutic potential of Curcuma longa, the golden spice of India, in drug discovery for ophthalmic diseases.The role of Müller glia and microglia in glaucoma.Neuroprotective therapies for glaucoma.Present and New Treatment Strategies in the Management of Glaucoma.The Role of Oxidative Stress and Vascular Insufficiency in Primary Open Angle Glaucoma.Glaucoma: Biological Trabecular and Neuroretinal Pathology with Perspectives of Therapy Innovation and Preventive Diagnosis.
P2860
Q26774852-438A32A9-DB62-46F9-84D4-FF2AEC0A261EQ26830700-4E57888A-FA08-43A0-8E3C-D9FCFE9BE860Q30978745-4435419B-C909-4655-944A-50F20F637EDEQ33311386-7D0A578F-7F3F-47E6-898E-A4C550ACEB19Q33477806-AFF62CFF-8DB7-4FC1-8A3E-B9F031B13885Q33789800-8127034A-08DC-4D0D-B78C-2DEFC77F8637Q34255732-BD7392B4-6573-40C9-A416-FF55A9DB3640Q34373200-7D7CEC01-244D-483E-8F94-62CA0CDDED8CQ34448394-55D29A89-40BD-4995-AAE7-42FA8E2A5731Q34755301-25051CE6-6553-44A1-BD84-652131E8203BQ35021422-ECC81D02-95F8-47C5-B19B-39E252249DCEQ35219534-A634ECCA-0397-45E3-A778-B6C521C74732Q35859027-64F1502C-B952-489F-96EB-ED0531B36017Q36379509-50C0EDB2-E0ED-4C97-B329-AFB4F8964458Q36539094-20DC5D6B-4279-46AA-9E74-CEFC2CA11C67Q36612019-20CEDF2E-7DFF-4411-8E47-8879D5A9E831Q36939711-ECB77C08-B794-440C-B0D0-B63B0CFF5149Q37106306-DFFDA5BF-CCDF-4DC2-A94E-9F61A8534196Q38031910-687CF4B4-02ED-4636-9701-D01700C80026Q38088355-89E085CA-8A93-4A2D-B4FA-647CFBEB47ABQ38115460-53B5BADC-7DB4-482D-9845-4305168C2EF5Q38384978-DBFDA655-A91F-40DB-80A8-7889CE1746F1Q38526185-7D8047F8-809C-4643-B2FE-728342ED5CDCQ38623215-4EF173AB-45DE-49F6-873D-2321B02C0110Q41455152-6AF49835-9C86-4FF6-BF08-FE674EB7C4CB
P2860
Pharmacologic neuroprotection with an inhibitor of nitric oxide synthase for the treatment of glaucoma.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Pharmacologic neuroprotection ...... for the treatment of glaucoma.
@ast
Pharmacologic neuroprotection ...... for the treatment of glaucoma.
@en
type
label
Pharmacologic neuroprotection ...... for the treatment of glaucoma.
@ast
Pharmacologic neuroprotection ...... for the treatment of glaucoma.
@en
prefLabel
Pharmacologic neuroprotection ...... for the treatment of glaucoma.
@ast
Pharmacologic neuroprotection ...... for the treatment of glaucoma.
@en
P1476
Pharmacologic neuroprotection ...... for the treatment of glaucoma.
@en
P2093
Arthur H Neufeld
P304
P356
10.1016/J.BRAINRESBULL.2003.07.005
P577
2004-02-01T00:00:00Z